Q1-Q2 2026 Revenue Exceeds 9M, Approaching Full-Year 2025 Level
From March to May 2026, Nanyang Zhang Zhongjing Biotech achieved revenue exceeding 9 million RMB in just three months, approaching the full-year level of 2025 (approximately 10 million RMB). The core team expanded to over 100 members, with over 400 at the production base. Cross-departmental synergy is evident, and growth continues to accelerate.
From March to May 2026, Nanyang Zhang Zhongjing Biotech achieved revenue exceeding 9 million RMB in just three months, approaching the full-year level of 2025 (approximately 10 million RMB).
The core team expanded to over 100 members, with over 400 at the production base. Cross-departmental synergy is evident, and growth continues to accelerate.